Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

SHA:688393 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.06	95.15	67.68	90.91	217.68	635.27
Trading Asset Securities	48.39	55.33	52.56	175.54	419.42	210.46
Cash & Short-Term Investments	96.45	150.48	120.25	266.45	637.1	845.73
Cash Growth	-1.00%	25.14%	-54.87%	-58.18%	-24.67%	395.81%
Accounts Receivable	220.83	242.84	245.25	239.03	211.94	185.47
Other Receivables	3.87	4.37	4.26	4.19	4.06	1.67
Receivables	224.71	247.21	249.51	243.22	216.01	187.14
Inventory	87.51	84.44	74.97	63.07	40.57	25.05
Prepaid Expenses	-	2.54	1.93	2.12	3.99	0.29
Other Current Assets	243.72	207.58	120.92	20.22	11.51	4.71
Total Current Assets	652.4	692.25	567.57	595.08	909.17	1,063
Property, Plant & Equipment	290.62	298.53	314.38	327.04	276.65	193.76
Long-Term Investments	106.75	241.91	402.48	373.52	86.07	7.5
Goodwill	26.46	26.46	26.46	29.52	29.52	8.09
Other Intangible Assets	6.23	5.58	6.47	5.78	5.85	5.77
Long-Term Deferred Tax Assets	39.02	35.63	27.61	19.04	12.69	12.38
Long-Term Deferred Charges	40.95	40.55	32.37	15.75	4.17	1.83
Other Long-Term Assets	167.3	21.81	22.59	27.06	41.56	-
Total Assets	1,330	1,363	1,400	1,393	1,366	1,292
Accounts Payable	34.59	32.68	37.14	32.59	49.76	55.89
Accrued Expenses	11.11	29.39	30.63	34.31	28.14	18.77
Short-Term Debt	2.15	7.3	21.2	14.3	7	-
Current Portion of Leases	1.72	1.49	2	3.26	2.54	-
Current Income Taxes Payable	2.62	0.88	3.02	2.1	2.11	5.92
Current Unearned Revenue	4.47	6.32	6.82	12.72	8.32	3.97
Other Current Liabilities	6.48	6.44	9.52	14.99	8.97	2.86
Total Current Liabilities	63.14	84.51	110.33	114.26	106.84	87.41
Long-Term Leases	1.54	1.65	5.18	7.24	2.85	-
Long-Term Unearned Revenue	27.35	27.54	28.19	28.94	29.89	30
Long-Term Deferred Tax Liabilities	13.79	13.37	14	16.08	13.34	7.26
Other Long-Term Liabilities	3.92	3.92	3.92	3.92	3.04	-
Total Liabilities	109.73	130.99	161.63	170.45	155.96	124.67
Common Stock	93.57	93.57	93.57	93.34	93.34	93.34
Additional Paid-In Capital	734.68	734.14	749.14	741.35	733.87	751.48
Retained Earnings	417.09	428.16	420.9	394.29	376.79	323.15
Comprehensive Income & Other	-0.17	-0.12	-	-0.38	-	-
Total Common Equity	1,245	1,256	1,264	1,229	1,204	1,168
Minority Interest	-25.18	-24	-25.31	-6.27	5.72	-0.39
Shareholders' Equity	1,220	1,232	1,238	1,222	1,210	1,168
Total Liabilities & Equity	1,330	1,363	1,400	1,393	1,366	1,292
Total Debt	5.42	10.44	28.39	24.8	12.39	-
Net Cash (Debt)	91.04	140.04	91.86	241.64	624.71	845.73
Net Cash Growth	2.38%	52.45%	-61.99%	-61.32%	-26.13%	395.81%
Net Cash Per Share	0.97	1.51	0.96	2.55	6.66	10.88
Filing Date Shares Outstanding	93.57	93.57	93.57	93.34	93.34	93.34
Total Common Shares Outstanding	93.57	93.57	93.57	93.34	93.34	93.34
Working Capital	589.26	607.74	457.23	480.81	802.34	975.5
Book Value Per Share	13.31	13.42	13.50	13.16	12.90	12.51
Tangible Book Value	1,212	1,224	1,231	1,193	1,169	1,154
Tangible Book Value Per Share	12.96	13.08	13.15	12.78	12.52	12.36
Buildings	-	256.64	256.58	238.97	216.44	43.62
Machinery	-	168.4	151.86	141.86	116.01	71.6
Construction In Progress	-	0.74	0.19	10.56	10.99	139.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.